Development of a microscale cell culture analog to probe naphthalene toxicity.
about
Biomedical microelectromechanical systems (BioMEMS): Revolution in drug delivery and analytical techniquesMicrofabricated mammalian organ systems and their integration into models of whole animals and humansAdvances in Engineered Liver Models for Investigating Drug-Induced Liver InjuryBiology-inspired microphysiological system approaches to solve the prediction dilemma of substance testingBioMEMS -Advancing the Frontiers of Medicine.Exploitation of physical and chemical constraints for three-dimensional microtissue construction in microfluidics.How multi-organ microdevices can help foster drug developmentBioreactor technologies to support liver function in vitro.Development of disposable PDMS micro cell culture analog devices with photopolymerizable hydrogel encapsulating living cells.Using physiologically-based pharmacokinetic-guided "body-on-a-chip" systems to predict mammalian response to drug and chemical exposureAlternative (non-animal) methods for cosmetics testing: current status and future prospects-2010.Microscale technologies for tissue engineering and biologyAllometric Scaling and Cell Ratios in Multi-Organ in vitro Models of Human Metabolism.Multi-cellular 3D human primary liver cell culture elevates metabolic activity under fluidic flow.Microengineered cell and tissue systems for drug screening and toxicology applications: Evolution of in-vitro liver technologies.Microfabrication technologies for oral drug delivery.Screening applications in drug discovery based on microfluidic technology.Cells on chips.Biomedical Technologies for in vitro Screening and Controlled Delivery of Neuroactive Compounds.Microengineered tumor models: insights & opportunities from a physical sciences-oncology perspectiveMicrofluidics for drug discovery and development: from target selection to product lifecycle management.Physiologically based pharmacokinetic models: integration of in silico approaches with micro cell culture analogues.Use of intrinsic clearance for prediction of human hepatic clearance.Design and application of microfluidic systems for in vitro pharmacokinetic evaluation of drug candidates.Integration of in silico and in vitro platforms for pharmacokinetic-pharmacodynamic modeling.Microfluidic devices for in vitro studies on liver drug metabolism and toxicity.From 3D cell culture to organs-on-chips.Microfluidic platforms for hepatocyte cell culture: new technologies and applications.Microtechnology for mimicking in vivo tissue environment.Modeling life.The future of microfluidic assays in drug development.Bioreactor engineering of stem cell environmentsOrgan-on-a-chip technology and microfluidic whole-body models for pharmacokinetic drug toxicity screening.Challenges and promises in modeling dermatologic disorders with bioengineered skin.Cell patterning for liver tissue engineering via dielectrophoretic mechanisms.In vitro micro-physiological models for translational immunology.The application of engineered liver tissues for novel drug discovery.Advancements in in vitro hepatic models: application for drug screening and therapeutics.The ascendance of microphysiological systems to solve the drug testing dilemma.Integration concepts for multi-organ chips: how to maintain flexibility?!
P2860
Q26768245-776C37E0-FDD7-4A08-A62F-ACCEDBBB5315Q27011459-93598720-8CB1-4C68-9118-F1D09B58A075Q28077505-9A511EC2-DBCC-4F91-96F9-2E96DB9680C1Q30358385-70B506DF-8BCC-49B1-8046-3934F073BFA0Q30452558-9DC2AAFB-EF2A-4FA5-86B0-B7F20C13E44DQ30474710-B495EF43-CB29-45B1-9D1A-623A5A2CF5A9Q33893475-646EB8A3-7063-4D41-9127-5EEAAD3468CDQ34087508-745E759F-374A-4325-8A2A-58E6427F55A4Q34097011-CF228E68-73D6-4962-ACD4-2BE07A5252C4Q34143269-FDFA39FB-7E9F-469C-B954-5E2A124BBC52Q34181630-E67A570A-E55D-4BB4-B721-0238DF3E7AF2Q34479429-8F9903A1-6373-41F2-8B04-C66C11133111Q34722881-B9974B34-9048-478F-8A5E-D8419A316E67Q35577829-B2A150B7-217B-422E-87F6-65F5BCFFB3F3Q35826421-EDB50395-9828-4260-85AE-2356496771BAQ36501907-A22D02C8-7DD7-4AD3-BE31-34E3C454966DQ36520996-DC630576-1A92-4D88-B7C7-BF060229DFE0Q36548320-A93D0B1D-7AE9-4FBD-AB52-87D1E2A6A875Q37010459-68EBA117-2F20-48E3-B4B9-FBFE48505670Q37022156-8F67B8DD-F182-4FB8-B06F-FA3BB4E91CFCQ37055383-BC4616DE-5FF2-4EAD-8EE8-A668084C2674Q37665888-F9ACF707-055B-4563-935F-42EF2989C4B9Q37674602-0645BE04-AFDB-480D-887A-C9C69F6515FEQ37694755-A935BA32-AE7E-45AE-8D90-F28303F37964Q37764345-4FC087CF-08B7-4C15-A389-A498BF53AA7FQ37844444-E79478E5-E291-4D0A-9307-03AF50EEC5B2Q37950229-B1C10A9F-9C83-4342-B463-12D2EE34DD87Q37951402-1C3060D0-5F57-4101-B6F4-6C479C1398C0Q37973002-9E750871-4F55-47F9-BA37-EFD5BFDF7FD4Q38004843-A9E874F5-63DE-47D0-BAAF-C2CDD7AF365CQ38089178-C443203A-1FD0-48CE-A836-51F3A643BBC2Q38093335-32E3CD57-26E2-48E4-A1C8-255444A16A53Q38137976-6FEF440F-B2ED-45A2-AEE5-E2EC009E7EB0Q38222089-6FFE6912-9395-4996-8574-7933A326B944Q38225910-0666C264-6944-4444-8178-32D33F450CF8Q38287065-14FFBDA5-FABE-47E2-8BF4-6986C4A92F91Q38404573-1CDAECDA-8880-45D1-87B3-CE4DF1488653Q38552408-FB56BF12-43B7-46D1-B4CE-CC3878621C43Q38663718-527D2C9C-A826-4834-8EBF-7C3B00EA4041Q38663725-BEDAF12E-D0EE-4B4A-AC9D-C3A4827501F6
P2860
Development of a microscale cell culture analog to probe naphthalene toxicity.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Development of a microscale cell culture analog to probe naphthalene toxicity.
@en
type
label
Development of a microscale cell culture analog to probe naphthalene toxicity.
@en
prefLabel
Development of a microscale cell culture analog to probe naphthalene toxicity.
@en
P2093
P356
P1476
Development of a microscale cell culture analog to probe naphthalene toxicity.
@en
P2093
Kwanchanok Viravaidya
Michael L Shuler
P304
P356
10.1021/BP0341996
P577
2004-01-01T00:00:00Z